Change involving the manufacturing of (biotinlated) antibody and antigen.
| Device | ADVIA CENTAUR HBSAG | 
| Classification Name | Test, Hepatitis B (b Core, Be Antigen, Be Antibody, B Core Igm) | 
| Generic Name | Test, Hepatitis B (b Core, Be Antigen, Be Antibody, B Core Igm) | 
| Applicant | SIEMENS HEALTHCARE DIAGNOSTICS | 
| Date Received | 2009-02-04 | 
| Decision Date | 2009-03-04 | 
| PMA | P030049 | 
| Supplement | S003 | 
| Product Code | LOM | 
| Advisory Committee | Microbiology | 
| Supplement Type | 30-day Notice | 
| Supplement Reason | Process Change - Manufacturer/sterilizer/packager/supplier | 
| Expedited Review | No | 
| Combination Product | No | 
| Applicant Address | SIEMENS HEALTHCARE DIAGNOSTICS 333 Coney Street walpole, MA 02032-1516 | 
Supplemental Filings
| Supplement Number | Date | Supplement Type | 
|---|
| P030049 |  | Original Filing | 
			        | S016 | 2020-12-22 | Real-time Process | 
			        | S015 | 2020-07-31 | 30-day Notice | 
			        | S014 | 2020-02-21 | 30-day Notice | 
			        | S013 | 2019-09-27 | 30-day Notice | 
			        | S012 | 2015-06-11 | 30-day Notice | 
			        | S011 | 2014-07-10 | Real-time Process | 
			        | S010 | 2012-03-26 | Normal 180 Day Track No User Fee | 
		        | S009 |  |  | 
			        | S008 | 2010-04-06 | 30-day Notice | 
			        | S007 | 2009-05-18 | Normal 180 Day Track | 
			        | S006 | 2009-05-12 | 30-day Notice | 
			        | S005 | 2009-03-31 | Normal 180 Day Track | 
			        | S004 | 2009-03-09 | Normal 180 Day Track No User Fee | 
			        | S003 | 2009-02-04 | 30-day Notice | 
			        | S002 | 2008-07-30 | Normal 180 Day Track | 
		        | S001 |  |  | 
NIH GUDID Devices